代谢物比值作为2型糖尿病潜在生物标志物:DIRECT研究
在130名健康双胞胎家庭成员中,于改良3小时高血糖钳夹试验的五个时间点检测188种血浆代谢物,并在OGTT队列(n=340)及患病(n=4925)和发病(n=4277)糖尿病病例对照研究中验证。发现缬氨酸与磷脂酰胆碱酰基-烷基C32:2比值(Val_PC ae C32:2)与胰岛素分泌、抵抗及2型糖尿病风险相关,且独立于已知危险因素。
要点
- Val_PC ae C32:2比值与OGTT衍生的胰岛素分泌和抵抗指标呈方向一致的阳性关联。
- Val_PC ae C32:2与现患2型糖尿病相关(OR 2.64,p=1.0×10-27)。
- Val_PC ae C32:2独立于已知危险因素预测新发糖尿病(HR 1.57,p=1.3×10-15)。
核心结论
- Val_PC ae C32:2代谢物比值与2型糖尿病风险增加及胰岛素分泌和抵抗指标相关,效应强于单个代谢物且独立于已知危险因素。
研究设计与样本
- 在130名来自荷兰双胞胎登记处的健康双胞胎家庭成员中,于改良3小时高血糖钳夹试验(含葡萄糖、GLP-1和精氨酸刺激)的五个时间点检测188种血浆代谢物。
- 在具有OGTT数据的队列(n=340)以及现患糖尿病(n=4925)和发病糖尿病(n=4277)的流行病学病例对照研究中验证结果。
- 数据采用回归模型分析,并校正潜在混杂因素。
主要发现
- 代谢物水平对不同促分泌剂呈现动态变化。
- 多种空腹成对代谢物比值与一个或多个钳夹衍生的胰岛素分泌指标相关(所有p<9.2×10-7),且这些关联显著强于单个代谢物组分。
- Val_PC ae C32:2比值与OGTT衍生的胰岛素分泌和抵抗指标呈方向一致的阳性关联(p≤5.4×10-3),并与现患2型糖尿病相关(OR 2.64 [β 0.97±0.09],p=1.0×10-27)。
- Val_PC ae C32:2独立于已知危险因素预测新发糖尿病(HR 1.57 [β 0.45±0.06],p=1.3×10-15),在两个队列中将该比值加入包含传统危险因素+葡萄糖的模型后,接收者操作特征曲线下面积分别从0.780升至0.801和从0.862升至0.865。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Circulating metabolites have been shown to reflect metabolic changes during the development of type 2 diabetes. In this study we examined the association of metabolite levels and pairwise metabolite ratios with insulin responses after glucose, glucagon-like peptide-1 (GLP-1) and arginine stimulation. We then investigated if the identified metabolite ratios were associated with measures of OGTT-derived beta cell function and with prevalent and incident type 2 diabetes. METHODS: We measured the levels of 188 metabolites in plasma samples from 130 healthy members of twin families (from the Netherlands Twin Register) at five time points during a modified 3 h hyperglycaemic clamp with glucose, GLP-1 and arginine stimulation. We validated our results in cohorts with OGTT data (n = 340) and epidemiological case-control studies of prevalent (n = 4925) and incident (n = 4277) diabetes. The data were analysed using regression models with adjustment for potential confounders. RESULTS: There were dynamic changes in metabolite levels in response to the different secretagogues. Furthermore, several fasting pairwise metabolite ratios were associated with one or multiple clamp-derived measures of insulin secretion (all p < 9.2 × 10-7). These associations were significantly stronger compared with the individual metabolite components. One of the ratios, valine to phosphatidylcholine acyl-alkyl C32:2 (PC ae C32:2), in addition showed a directionally consistent positive association with OGTT-derived measures of insulin secretion and resistance (p ≤ 5.4 × 10-3) and prevalent type 2 diabetes (ORVal_PC ae C32:2 2.64 [β 0.97 ± 0.09], p = 1.0 × 10-27). Furthermore, Val_PC ae C32:2 predicted incident diabetes independent of established risk factors in two epidemiological cohort studies (HRVal_PC ae C32:2 1.57 [β 0.45 ± 0.06]; p = 1.3 × 10-15), leading to modest improvements in the receiver operating characteristics when added to a model containing a set of established risk factors in both cohorts (increases from 0.780 to 0.801 and from 0.862 to 0.865 respectively, when added to the model containing traditional risk factors + glucose). CONCLUSIONS/INTERPRETATION: In this study we have shown that the Val_PC ae C32:2 metabolite ratio is associated with an increased risk of type 2 diabetes and measures of insulin secretion and resistance. The observed effects were stronger than that of the individual metabolites and independent of known risk factors.
引用
- Molnos S, Wahl S, Haid M, et al. Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study. Diabetologia. 2017. PMID: 28936587. doi:10.1007/s00125-017-4436-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。